Cargando…
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
Coronaviruses (CoVs) are a group of RNA viruses that are associated with different diseases in animals, birds, and humans. Human CoVs (HCoVs) have long been known to be the causative agents of mild respiratory illnesses. However, two HCoVs associated with severe respiratory diseases are Severe Acute...
Autor principal: | Elshabrawy, Hatem A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350231/ https://www.ncbi.nlm.nih.gov/pubmed/32585913 http://dx.doi.org/10.3390/vaccines8020335 |
Ejemplares similares
-
SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021) -
Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022) -
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021) -
An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
por: Hillary, Varghese Edwin, et al.
Publicado: (2023) -
Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)